A novel monoclonal antibody to a defined peptide epitope in MUC16

15Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The MUC16 mucin is overexpressed and aberrantly glycosylated in ovarian carcinomas. Immunodetection of circulating MUC16 is one of the most used cancer biomarker assays, but existing antibodies to MUC16 fail to distinguish normal and aberrant cancer glycoforms. Although all antibodies react with the tandem-repeat region, their epitopes appear to be conformational dependent and not definable by a short peptide. Aberrant glycoforms of MUC16 may constitute promising targets for diagnostic and immunotherapeutic intervention, and it is important to develop well-defined immunogens for induction of potent MUC16 immunity. Here, we developed a MUC16 vaccine based on a 1.7TR (264 aa) expressed in Escherichia coli and in vitro enzymatically glycosylated to generate the aberrant cancer-associated glycoform Tn. This vaccine elicited a potent serum IgG response in mice and we identified two major immunodominant linear peptide epitopes within the tandem repeat. We developed one monoclonal antibody, 5E11, reactive with a minimum epitope with the sequence FNTTER. This sequence contains potential N-and O-glycosylation sites and, interestingly, glycosylation blocked binding of 5E11. In immunochemistry of ovarian benign and cancer lesions, 5E11 showed similar reactivity as traditional MUC16 antibodies, suggesting that the epitope is not efficiently glycosylated. The study provides a vaccine design and immunodominant MUC16 TR epitopes.

References Powered by Scopus

A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer

2006Citations
N/AReaders
Get full text

Reactivity of a monoclonal antibody with human ovarian carcinoma

1524Citations
N/AReaders
Get full text

Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology

1096Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Cancer-associated mucins: role in immune modulation and metastasis

179Citations
N/AReaders
Get full text

MUC16 as a novel target for cancer therapy

157Citations
N/AReaders
Get full text

Short O-GalNAc glycans: Regulation and role in tumor development and clinical perspectives

108Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Marcos-Silva, L., Ricardo, S., Chen, K., Blixt, O., Arigi, E., Pereira, D., … Clausen, H. (2015). A novel monoclonal antibody to a defined peptide epitope in MUC16. Glycobiology, 25(11), 1172–1182. https://doi.org/10.1093/glycob/cwv056

Readers over time

‘15‘16‘17‘18‘20‘21‘22‘23‘2402468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 12

52%

Researcher 7

30%

Professor / Associate Prof. 4

17%

Readers' Discipline

Tooltip

Chemistry 8

40%

Biochemistry, Genetics and Molecular Bi... 7

35%

Agricultural and Biological Sciences 3

15%

Chemical Engineering 2

10%

Save time finding and organizing research with Mendeley

Sign up for free
0